Latest market price
24.11
-0.61-2.47%
News
Down 2.5% — AstraZeneca results: 9M and Q3 2026 (businesswire.com).
Medium confidence
TA
Loading chart...
Snapshot
| Index | — | P/E | 8.86 | EPS (ttm) | 2.72 | Insider Own | 1.23% | Shs Outstand | 261.18M | Perf Week | 0.04% |
| Market Cap | 6.30B | Forward P/E | 10.23 | EPS next Y | 2.36 | Insider Trans | -0.83% | Shs Float | 260.17M | Perf Month | 5.93% |
| Enterprise Value | 10.09B | PEG | 2.29 | EPS next Q | -0.18 | Short Float | 13.35% | Perf Quarter | -7.09% | ||
| Income | 749.00M | P/S | 0.28 | EPS this Y | 5.51% | Short Ratio | 5.83 | Perf Half Y | 22.45% | ||
| Sales | 22.78B | P/B | 1.28 | EPS next Y | 2.08% | ROA | 4.76% | Short Interest | 34.72M | Perf YTD | 9.34% |
| Book/sh | 18.87 | P/C | 4.87 | EPS next 5Y | 3.87% | ROE | 15.81% | 52W High | 26.59 -9.33% | Perf Year | 23.39% |
| Cash/sh | 4.95 | P/FCF | 4.22 | EPS past 3/5Y | -17.88% — | ROIC | 7.22% | 52W Low | 16.69 44.46% | Perf 3Y | 108.38% |
| Dividend Est. | 0.77 (3.18%) | EV/EBITDA | 4.96 | Sales past 3/5Y | -3.85% 4.56% | Gross Margin | 36.03% | Volatility | 3.83% 3.69% | Perf 5Y | -9.33% |
| Dividend TTM | 0.76 (3.14%) | EV/Sales | 0.44 | EPS Y/Y TTM | 54.59% | Oper. Margin | 4.88% | ATR (14) | 0.88 | Perf 10Y | -32.79% |
| Dividend Ex-Date | Dec 15, 2026 | Quick Ratio | 0.48 | Sales Y/Y TTM | 0.34% | Profit Margin | 3.29% | RSI (14) | 56.83 | Recom | 2.85 |
| Dividend Gr. 3/5Y | 5.01% 14.09% | Current Ratio | 1.59 | EPS Q/Q | 53.66% | SMA20 | 2.91% | Beta | 1.39 | Target Price | 24.25 |
| Payout | 26.44% | Debt/Eq | 1.03 | Sales Q/Q | 1.20% | SMA50 | 5.78% | Rel Volume | 0.91 | Prev Close | 24.72 |
| Employees | 90,134 | LT Debt/Eq | 1.03 | Earnings | Dec 02 | SMA200 | 11.31% | Avg Volume | 6.14M | Price | 24.11 |
| IPO Date | Feb 05, 1992 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 69.99% 1.27% | Net Debt/EBITDA | 1.86 | Volume | 5,564,299 | Change | -2.47% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jul-06-26 | Resumed | Morgan Stanley | Overweight | $16 → $30 |
| Jun-04-26 | Reiterated | Telsey Advisory Group | Market Perform | $22 → $23 |
| Jun-04-26 | Reiterated | Evercore ISI Group | In Line | $21 → $22 |
| Jun-03-26 | Reiterated | Gordon Haskett Capital Corporation | $20 → $22 | |
| Mar-18-26 | Reiterated | Jefferies | Buy | $27 → $22 |
| Mar-09-26 | Reiterated | UBS | Sell | $21 → $9.00 |
| Dec-12-25 | Reiterated | Jefferies | Buy | $26 → $27 |
| Dec-05-25 | Reiterated | Goldman Sachs | Neutral | $12 → $22 |
| Dec-05-25 | Reiterated | Evercore ISI Group | In Line | $17 → $21 |
| Dec-04-25 | Reiterated | Jefferies | Buy | $19 → $26 |
Latest News· Times ET
Oct-30-26
Oct-30-2606:46PM
07:00AM
AstraZeneca results: 9M and Q3 2026businesswire.com
Oct-28-26
Oct-28-2605:00AM
Oct-27-26
Oct-27-2605:44PM
12:06PM
Macy's Unwraps the Magic of Holiday Giftingbusinesswire.com
Oct-26-26
Oct-23-26
Oct-22-26
Oct-20-26
Oct-19-26
01:30PM
07:45AM
Oct-15-26
Oct-14-26
Company
Macy's, Inc. is a prominent retail enterprise that employs an omnichannel strategy, serving customers through its extensive network of physical department stores, dedicated e-commerce websites, and convenient mobile applications. The company offers a broad assortment of merchandise, including apparel and accessories for men, women, and children, cosmetics, home furnishings, and other general consumer goods. As of January 29, 2022, Macy's operated 725 department stores domestically in locations such as the District of Columbia, Puerto Rico, and Guam. These stores are branded under several well-known names like Macy's, Macy's Backstage, Market by Macy's, Bloomingdale's, Bloomingdale's The Outlet, Bloomies, and the beauty retailer bluemercury. Internationally, Macy's also extends its reach through licensing agreements, with operations in Dubai, United Arab Emirates, and Al Zahra, Kuwait. The company maintains a presence in the beauty and spa retail sector. Originally established in 1830, the company was previously known as Federated Department Stores, Inc. It officially changed its name to Macy's, Inc. in June 2007, and its corporate headquarters are located in New York, New York.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 1/31/2026 | FY 2024 2/1/2025 | FY 2023 2/3/2024 | FY 2022 1/28/2023 | FY 2021 1/29/2022 | FY 2020 1/30/2021 | FY 2019 1/31/2020 | FY 2018 1/31/2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 22,780 | 22,621 | 23,006 | 23,866 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 14,573 | 14,354 | 13,740 | 14,224 | — | — | — | — | — | |
| Gross Profit | 8,207 | 8,267 | 9,266 | 9,642 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 1,146,117 | 8,240 | 8,330 | 8,375 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | -1,139,022 | -1,003 | 27 | 966 | — | — | — | — | — | |
| Operating Income | 1,112 | 1,030 | 909 | 301 | — | — | — | — | — | |
| Interest Expense | 93 | 97 | 115 | 135 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -33 | -84 | -31 | -123 | — | — | — | — | — | |
| Net Income Before Taxes | 986 | 849 | 763 | 43 | — | — | — | — | — | |
| Income Taxes | 237 | 207 | 181 | -2 | — | — | — | — | — | |
| Consolidated Net Income | 749 | 642 | 582 | 45 | — | — | — | — | — | |
| Net Income From Continuing Operations | 749 | 642 | 582 | 45 | — | — | — | — | — | |
| Net Income | 749 | 642 | 582 | 45 | — | — | — | — | — | |
| EPS (Recurring) | 2.79 | 2.37 | 2.10 | 0.16 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 2.79 | 2.37 | 2.10 | 0.16 | — | — | — | — | — | |
| EPS (Diluted) | 2.72 | 2.32 | 2.07 | 0.16 | — | — | — | — | — | |
| EBITDA | 2,036 | 1,840 | 1,759 | 1,075 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 8.86 | 8.63 | 7.53 | 116.44 | — | — | — | — | — | |
| Price To Sales Ratio | 0.28 | 0.24 | 0.19 | 0.21 | — | — | — | — | — | |
| Gross Margin | 36.03 | 36.55 | 40.28 | 40.40 | — | — | — | — | — | |
| Operating Margin | 4.88 | 4.55 | 3.95 | 1.26 | — | — | — | — | — | |
| Net Margin | 3.29 | 2.84 | 2.53 | 0.19 | — | — | — | — | — | |
| Shares Outstanding | 264 | 271 | 281 | 274 | — | — | — | — | — | |
| Market Capitalization | 6,365 | 5,425 | 4,378 | 5,105 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Griscom Paul | SVP and Controller | Jun 25 '26 | Sale | 25.63 | 10,077 | 258,278 | 25,373 | Jun 26 |
| Edwards Thomas Jr. | EVP, COO & CFO | Jun 24 '26 | Sale | 24.89 | 16,419 | 408,726 | 20,000 | Jun 24 |
| Edwards Thomas Jr. | EVP, COO & CFO | Jun 23 '26 | Option Exercise | 0.00 | 36,419 | 0 | 36,419 | Jun 24 |
| Kirgan Danielle L. | EVP, Chief HR Officer | Apr 06 '26 | Sale | 17.92 | 10,010 | 179,408 | 108,008 | Apr 07 |
| Bron Olivier | CEO, Bloomingdale's | Apr 06 '26 | Sale | 17.92 | 7,228 | 129,555 | 21,590 | Apr 07 |
| Spring Antony | Chairman & CEO | Apr 06 '26 | Sale | 17.92 | 50,044 | 896,984 | 485,791 | Apr 07 |
| Griscom Paul | SVP and Controller | Apr 06 '26 | Sale | 17.92 | 745 | 13,353 | 35,450 | Apr 07 |
| Preston Tracy M | EVP, CLO & Corporate Secretary | Apr 06 '26 | Sale | 17.92 | 5,271 | 94,481 | 28,773 | Apr 07 |
| Griscom Paul | SVP and Controller | Apr 03 '26 | Option Exercise | 0.00 | 2,629 | 0 | 36,195 | Apr 07 |
| Bron Olivier | CEO, Bloomingdale's | Apr 03 '26 | Option Exercise | 0.00 | 13,146 | 0 | 28,818 | Apr 07 |
| Kirgan Danielle L. | EVP, Chief HR Officer | Apr 03 '26 | Option Exercise | 0.00 | 19,719 | 0 | 118,018 | Apr 07 |
| Preston Tracy M | EVP, CLO & Corporate Secretary | Apr 03 '26 | Option Exercise | 0.00 | 13,146 | 0 | 34,044 | Apr 07 |
| Spring Antony | Chairman & CEO | Apr 03 '26 | Option Exercise | 0.00 | 98,597 | 0 | 535,835 | Apr 07 |
| Kirgan Danielle L. | EVP, Chief HR Officer | Apr 01 '26 | Sale | 18.08 | 6,573 | 118,817 | 98,299 | Apr 02 |
| Griscom Paul | SVP and Controller | Apr 01 '26 | Sale | 18.08 | 490 | 8,857 | 33,566 | Apr 02 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.